Cargando…

Efficacy and Safety of Novel Oral Anticoagulants in Atrial Fibrillation: A Systematic Review

In recent times, novel oral anticoagulants (NOACs)/direct oral anticoagulants (DOACs) have emerged as an alternative to the traditionally used Vitamin K oral antagonists (VKA) like warfarin for the treatment of atrial fibrillation (AF). This systematic review and meta-analysis aims to evaluate the e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basu Roy, Prithvi, Tejani, Vitrag N, Dhillon, Sukhmeet S, Damarlapally, Nanush, Winson, Tanusha, Usman, Nia Uswanti Binti, Panjiyar, Binay K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620341/ https://www.ncbi.nlm.nih.gov/pubmed/37927673 http://dx.doi.org/10.7759/cureus.46385

Ejemplares similares

The Relationship Between Dietary Fiber Intake and Blood Pressure Worldwide: A Systematic Review
por: Tejani, Vitrag N, et al.
Publicado: (2023)

The Impact of Statin Therapy on Cardiovascular Outcomes in Patients With Diabetes: A Systematic Review
por: Usman, Nia Uswanti Binti, et al.
Publicado: (2023)

Comparative Effectiveness of Different Anticoagulation Strategies in Atrial Fibrillation and Renal Dysfunction: A Systematic Review
por: Ghantiwala, Kunj R, et al.
Publicado: (2023)

Navigating the Immune Challenge in Glioblastoma: Exploring Immunotherapeutic Avenues for Overcoming Immune Suppression
por: Jain, Prateek, et al.
Publicado: (2023)

Role of Cardiac Troponins in Predicting Adverse Outcomes in Acute Coronary Syndrome With Renal Dysfunction
por: Noorayingarath, Hafseena, et al.
Publicado: (2023)

Cardiovascular Benefits of Resistance Training in Patients With Heart Failure With Reduced Ejection Fraction: A Systematic Review
por: Danduboyina, Anirudh, et al.
Publicado: (2023)

Role of Cardiac Biomarkers in the Evaluation of Rheumatoid Arthritis: A Systematic Review
por: Borra, Saatvika R, et al.
Publicado: (2023)

Inflammation in Cardiovascular Disease: A Comprehensive Review of Biomarkers and Therapeutic Targets
por: Gupta, Lovish, et al.
Publicado: (2023)

The Interplay Between Sleep Disorders and Cardiovascular Diseases: A Systematic Review
por: Ravichandran, Rakshana, et al.
Publicado: (2023)

Safety and Efficacy of Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors vs. Erythropoietin-Stimulating Agents in Treating Anemia in Renal Patients (With or Without Dialysis): A Meta-Analysis and Systematic Review
por: Damarlapally, Nanush, et al.
Publicado: (2023)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Role of Anticoagulants for Stroke Prevention in Low-Risk Population Having Atrial Fibrillation and Chronic Kidney Disease: A Systematic Review
por: Ravi, Niriksha, et al.
Publicado: (2022)

The new oral anticoagulants in atrial fibrillation: an update
por: Verheugt, F. W. A.
Publicado: (2013)

Satisfaction with oral anticoagulants in patients with atrial fibrillation
por: Suárez Fernández, Carmen, et al.
Publicado: (2018)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Common Sleep Disorders in Patients With Chronic Kidney Disease: A Systematic Review on What They Are and How We Should Treat Them
por: Davydov, Gershon G, et al.
Publicado: (2023)

Impact of Weight Loss on Atrial Fibrillation
por: Ahammed, Md Ripon, et al.
Publicado: (2023)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)

Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation
por: da Silva, Rose M.F.L.
Publicado: (2014)

Characterization of patients with atrial fibrillation not treated with oral anticoagulants
por: Johansson, Cecilia, et al.
Publicado: (2014)

Oral Anticoagulants for Atrial Fibrillation Patients with Active Cancer
por: Kim, Do Young, et al.
Publicado: (2018)

Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation
por: Giustozzi, Michela, et al.
Publicado: (2019)

Novel Oral Anticoagulants in Atrial Fibrillation: Update on Apixaban
por: Mezue, Kenechukwu, et al.
Publicado: (2017)

Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation
por: Reiffel, James A.
Publicado: (2018)

The temporal context of oral anticoagulation outcome in atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2022)

Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation
por: Galea, Roberto, et al.
Publicado: (2023)

Anticoagulation in atrial fibrillation: the present and the future
por: Dweck, Marc R, et al.
Publicado: (2012)

Anticoagulation for atrial fibrillation in active cancer
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Improvement in the Management of Oral Anticoagulation in Patients with Atrial Fibrillation in Primary Health Care
por: García-Roy, África, et al.
Publicado: (2022)

Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants
por: Ng, Kuan H., et al.
Publicado: (2013)

Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service
por: Vedovati, Maria Cristina, et al.
Publicado: (2022)

Patients and Their Physician’s Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an Anticoagulant
por: Cannon, Christopher P., et al.
Publicado: (2023)

Dronedarone-induced Phototoxicity in a Patient with Atrial Fibrillation
por: Datar, Praveen, et al.
Publicado: (2019)

Trends in Oral Anticoagulation Therapy Among Korean Patients With Atrial Fibrillation: The KORean Atrial Fibrillation Investigation
por: Shin, Hong-Won, et al.
Publicado: (2012)

Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
por: Ferro, D., et al.
Publicado: (2007)

Efficacy and safety of oral anticoagulation in elderly patients with atrial fibrillation
por: Cavallari, Ilaria, et al.
Publicado: (2018)

Oral Anticoagulants in Japanese Patients with Atrial Fibrillation and Active Cancer
por: Yasui, Taku, et al.
Publicado: (2019)

Factors Influencing Oral Anticoagulant Prescribing Practices for Atrial Fibrillation
por: Leung, Lester Y., et al.
Publicado: (2017)

Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation
por: Prídavková, Dana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h5ef8cgnmk8ierf38c3nfojr23